- ILMN -2.29%
Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript
Yahoo Finance · 3 weeks ago
Open | 111.30 |
High | 111.53 |
Low | 108.27 |
Mkt Cap | 17.29B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 111.07 |
52 Wk. Low | 89.00 |
52 Wk. High | 213.91 |
Related stocks
American company that develops systems for the analysis of genetic variation
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 1.08B | 1.00% ▼ |
Net Income | -126M | - |
Diluted EPS | 0.09 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.08 | - |
Q1 2024 | $0.04 | $0.09 |
Q4 2023 | $0.02 | $0.14 |
S&P FuturesES=F | 5,333.75+2.00 (+0.04%) |
Dow FuturesYM=F | 39,948.00+4.00 (+0.01%) |
Nasdaq FuturesNQ=F | 18,754.50-8.50 (-0.05%) |
323.77+1.86% | |
Ethereum USDETH-USD | 3,656.18+17.79% |
18.60+27.66% |